Tag: EP

BioSig AI Sciences Selected for NVIDIA Inception Partnership Program to Support R&D Collaboration on AI Medical Device Platform for Hospitals

Westport, CT, July 20, 2023 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to intracardiac signal visualization, today announced that its subsidiary BioSig AI Sciences, Inc. (BAIS) was selected […]

Update: BioSig’s PURE EP™ System Demonstrates Potential Time and Cost Savings at the 15th APHRS Scientific Session in Singapore

Abstract highlights promising results from PURE EP™ study at premier Asia-Pacific Heart Rhythm Society Conference Westport, CT, Dec. 14, 2022 (GLOBE NEWSWIRE) — – BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering unprecedented […]

Heart Rhythm Society Kicks Off Annual Scientific Sessions In Boston To Unveil Scientific Advances And Innovations In Cardiac Arrhythmia Care

BOSTON, May 8, 2018 /PRNewswire/ — Thousands of clinicians, scientists, researchers and innovators from around the world will gather together Wednesday, May 9 through Saturday, May 12 at the Boston Convention and Exhibition Center for Heart Rhythm 2018, the Heart Rhythm Society’s (HRS) 39th Annual Scientific Sessions, […]

BioSig Technologies Adds Role of Manufacturing Project Leader as Company Continues to Advance Towards Commercialization

Minneapolis, MN, Oct. 24, 2017 (GLOBE NEWSWIRE) — BioSig Technologies(OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that the Company has engaged Quintain […]

BioSig Technologies Advances Towards Commercialization into the Global Electrophysiology Market Estimated to Reach $8.2 Billion by 2022

Minneapolis, MN, Oct. 19, 2017 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need within the emerging electrophysiology (EP) marketplace, announced today that they have made significant […]